Logo

American Heart Association

  14
  0


Final ID: MP1754

Hemodynamic Subtypes of Pulmonary Hypertension Based on Right Heart Catheterization Data Predict Outcomes in ICI-Associated Myocarditis

Abstract Body (Do not enter title and authors here): Background: Pulmonary hypertension (PH) is a known complication in patients with cancer, arising from both therapies and malignancies. Immune checkpoint inhibitor (ICI)-associated myocarditis has been linked to PH in case reports, but its impact on patient outcomes remains unclear. Diverse hemodynamic profiles of pre-capillary, isolated post-capillary, and combined pre- and post-capillary PH may influence prognosis in this population.
Research Question: To investigate the prevalence of PH and its hemodynamic subtypes in patients with ICI-associated myocarditis and evaluate their impact on clinical outcomes, including survival and major adverse cardiac events (MACE).
Methods: This retrospective cohort study included 67 patients diagnosed with ICI-associated myocarditis at MD Anderson Cancer Center from August 2013 to December 2023 who underwent right heart catheterization. Patients were classified per 2022 ESC/ERS guidelines: pre-capillary (PCWP ≤15 mmHg, PVR >2 WU), isolated post-capillary (PCWP >15 mmHg, PVR <2 WU), and combined (PCWP >15 mmHg, PVR ≥2 WU). Clinical features, hemodynamics, and outcomes (mortality, MACE) were compared using chi-square and Mann-Whitney U tests. Univariable time to event analysis for clinical outcomes was done with Kaplan-Meier survival analysis.
Results: PH was present in 55.2% (37/67) of patients, with pre-capillary PH (27.0%), isolated post-capillary PH (48.6%), and combined PH (24.3%). Combined and isolated post-capillary PH had higher right atrial pressures than pre-capillary PH (12.89 ± 3.76 mmHg, 11.94 ± 3.33 mmHg, 8.60 ± 1.84 mmHg, p = 0.0087). Combined PH had the highest mean pulmonary artery pressure (32.07 ± 6.41 mmHg, p = 0.0232). While 90-day mortality (40.5% vs 46.7%, p = 0.615) and MACE (54.1% vs 40%, p = 0.252) for PH and non-PH groups were similar, 90-day survival was significantly lower in pre-capillary PH versus other PH subgroups (40.0% vs 77.8%, p = 0.0389).
Conclusions: This study demonstrates a significant burden of PH in ICI-associated myocarditis patients, with a substantial proportion of pre-capillary PH, which was associated with the worst survival outcomes. Our findings emphasize the prognostic significance of hemodynamic classification in this population. Future studies are needed to elucidate pathophysiologic mechanisms and identify targeted therapies for ICI-associated PH.
  • Wang, Emily  ( RWJ Medical School , Piscataway , New Jersey , United States )
  • Palaskas, Nicolas  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Ali, Hyeon-ju  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Ostos Mendoza, Keila  ( Tecnologico de Monterrey , Chihuahua , Mexico )
  • Koutroumpakis, Efstratios  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Khalaf, Shaden  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Hamzeh, Ihab  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Kumar, Salil  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Iliescu, Cezar  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Deswal, Anita  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Author Disclosures:
    Emily Wang: DO NOT have relevant financial relationships | Nicolas Palaskas: DO have relevant financial relationships ; Consultant:Kiniksa Pharmaceuticals:Active (exists now) | Hyeon-Ju Ali: No Answer | Keila Ostos Mendoza: DO NOT have relevant financial relationships | Efstratios Koutroumpakis: No Answer | Shaden Khalaf: DO NOT have relevant financial relationships | Ihab Hamzeh: No Answer | Salil Kumar: No Answer | Cezar Iliescu: No Answer | Anita Deswal: DO have relevant financial relationships ; Consultant:Bayer:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Clinical Challenges in Pulmonary Hypertension

Sunday, 11/09/2025 , 11:50AM - 01:00PM

Moderated Digital Poster Session

More abstracts on this topic:
More abstracts from these authors:
Emergence of Hypertension in Thyroid Cancer Patients on BRAF ± MEK Inhibitors: A Closer Look at Incidence and Contributing Risk Factors

Ebrahimi Sara, Busaidy Naifa, Palaskas Nicolas, Hu Mimi, Waguespack Steven, Cabanillas Maria, Deswal Anita, Hamidi Sarah, Song Juhee, Baser Hatice D., Koutroumpakis Efstratios, Ali Hyeon-ju, Kumar Salil, Iyer Priyanka, Dadu Ramona

Risk Assessment for Cardiac Adverse Events with Bruton’s Tyrosine Kinase Inhibitors in Patients with Mantle Cell Lymphoma

Ali Abdelrahman, Iliescu Cezar, Jain Preetesh, Deswal Anita, Ynalvez Leslie, Song Juhee, Koutroumpakis Efstratios, Ali Hyeon-ju, Khalaf Shaden, Mendoza Keila, Yusuf Syed, Palaskas Nicolas

You have to be authorized to contact abstract author. Please, Login
Not Available